by Annie De Groot | Apr 7, 2020 | Events, Thinking Out Loud -Blog, Webinars
This webinar has passed. You may watch the recorded recap here. We invite you to join us on May 15, 2020 for “Immune Engineering Human B cell-Derived Antibodies for Emerging Infectious Diseases” Please extend this invitation to any colleagues or associates...
by Annie De Groot | Mar 30, 2020 | News
With 22 years of experience, EpiVax is in the ‘perfect position’ to figure out how to immunize people, founder says By Edward Fitzpatrick Globe Staff,Updated March 30, 2020, 6:00 a.m. Read the full text here. The Boston Globe’s weekly Ocean State Innovators column...
by Annie De Groot | Mar 27, 2020 | Events, Featured, Thinking Out Loud -Blog
Team EpiVax remains hard at work through this global health crisis. Our scientists are dedicated to the cause while navigating new office protocols. Our fearless leaders Annie De Groot and Bill Martin remain on site at our Olneyville office, along with other key...
by Annie De Groot | Mar 27, 2020 | News
March 26, 2020 04:42 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced it has reduced the timeline from biopsy to vaccine to under 4 weeks for its personalized neoantigen...
by Annie De Groot | Mar 24, 2020 | Featured, News
March 24, 2020 Niel, Belgium: eTheRNA Immunotherapies nv (‘eTheRNA’ or ‘The Company’), a clinical-stage company developing vaccines and immunotherapies from its proprietary mRNA TriMix platform, today announced that a consortium has been formed with North American and...